Cholinesterase inhibitors affect disease progression in Alzheimer's disease

被引：0

作者：

Marini, S. ^{[1
]}

Bessi, V. ^{[1
]}

Padiglioni, S. ^{[1
]}

Nacmias, B. ^{[1
]}

Bagnoli, S. ^{[1
]}

Sorbi, S. ^{[1
]}

Bracco, L. ^{[1
]}

机构：

[1] Univ Florence, Florence, Italy

来源：

JOURNAL OF NEUROLOGY | 2013年 / 260卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P665

引用

页码：S165 / S165

页数：1

共 50 条

[21] ADHERENCE TO CHOLINESTERASE INHIBITORS IN PATIENTS WITH ALZHEIMER'S DISEASE
Blais, Lucie
Kettani, Fatima-Zohra
Perreault, Sylvie
Leroux, Jean-Christophe
Forget, Amelie
Kergoat, Marie-Jeanne
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 (02) : 366 - 368
[22] Switching cholinesterase inhibitors in patients with Alzheimer's disease
Emre, M
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, : 64 - 72
[23] Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease
Jönsson, L
PHARMACOECONOMICS, 2003, 21 (14) : 1025 - 1037
[24] Adherence to Cholinesterase Inhibitors in Alzheimer's Disease: A Review
Brady, Roseanna
Weinman, John
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2013, 35 (5-6) : 351 - 363
[25] Current treatments for Alzheimer's disease: Cholinesterase inhibitors
Doody, RS
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 : 11 - 17
[26] Treatment of advanced Alzheimer's disease with cholinesterase inhibitors
Korczyn, Amos D.
ALZHEIMERS & DEMENTIA, 2008, 4 (05) : 371 - 372
[27] A clinical overview of cholinesterase inhibitors in Alzheimer's disease
Farlow, M
INTERNATIONAL PSYCHOGERIATRICS, 2002, 14 : 93 - 126
[28] Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly
Vandenberg, CM
Kazmi, Y
Jann, MW
DRUGS & AGING, 2000, 16 (02) : 123 - 138
[29] Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
Tayeb, Haythum O.
Yang, Hyun Duk
Price, Bruce H.
Tarazi, Frank I.
PHARMACOLOGY & THERAPEUTICS, 2012, 134 (01) : 8 - 25
[30] Cholinesterase Inhibitors for the Treatment of Alzheimer’s Disease in the Elderly
Chad M. VanDen Berg
Yusuf Kazmi
Michael W. Jann
Drugs & Aging, 2000, 16 : 123 - 138

← 1 2 3 4 5 →